A lab-made fragment of a natural healing protein (Thymosin Beta-4) involved in tissue and muscle repair.
Muscle, tendon, and wound recovery.
The fragment itself has no human trials, raises a cancer-related caution, and is banned in tested sports.
What it is
TB-500 is a synthetic version of the active portion of a naturally occurring protein called Thymosin Beta-4, which is found in virtually every cell in your body and plays a key role in how cells organize, move, and respond to injury. When tissue is damaged, Thymosin Beta-4 is released at high concentrations at the injury site, where it helps coordinate healing by activating repair cells, modulating inflammation, and supporting new tissue formation. TB-500 is specifically the fragment corresponding to amino acids 17 through 23 — the region researchers identified as the most biologically active. An important distinction: this is not the same as Thymosin Alpha-1 (peptide 03 in this guide), which is a completely different compound that works through immune modulation. TB-500 is also on the WADA prohibited list, meaning anyone subject to competitive sports drug testing cannot use it. The fragment itself has not been studied in human clinical trials, though the full Thymosin Beta-4 molecule has been in Phase 2 cardiac research with modest, mixed results.
Potential benefits
Tissue & Wound Repair — Primary Application
TB4 is a known wound healing promoter with legitimate academic research. Animal studies consistently show accelerated healing of muscle, tendon, ligament, and skin. The biological foundation is solid for the full peptide.
Muscle Repair & Recovery
Promotes satellite cell (muscle stem cell) activation. Accelerates muscle repair and reduces fibrotic scarring in animal injury models.
Anti-Inflammatory
Reduces inflammatory cytokines, modulates macrophage activity at wound sites. Supports the healing environment.
Cardiac & Neurological Protection
Animal studies show cardiac and CNS protective effects. Full TB4 studied in Phase 2 cardiac trials with modest mixed results. TB-500 fragment-specific cardiac data limited.
Risks and contraindications
Side Effects
- Injection site reactions — standard
- Fatigue — first days of use
- Headache · Nausea
- Head rush or lightheadedness shortly after injection
- Compound quality risk — research chemical, no manufacturing standards
Theoretical Risks
- Cancer promotion: TB4 overexpressed in several human cancers; cell migration and survival signaling could support cancer cell behavior
- Angiogenesis promotion — same theoretical cancer concern as BPC-157
- Long-term actin dynamics modulation — fundamental cell function, chronic effects unknown
Contraindications / cautions
- Active cancer or cancer history — TB4 overexpression in cancers is documented
- Competitive athletes subject to WADA/USADA testing — prohibited substance
- Pregnancy · Under 18
- Combining with other healing peptides (BPC-157, GHK-Cu) — stacked angiogenesis effects unstudied
Research reality
Extensive and independently replicated for tissue repair, wound healing, and cardiac protection. The biology of Thymosin Beta-4 in wound healing is genuinely taken seriously in academic medicine, not just the peptide wellness space.
The full TB4 molecule has Phase 2 cardiac trial data and an FDA Orphan Drug Designation. The TB-500 fragment specifically has NOT been studied in human clinical trials. Human evidence for TB-500 is extrapolated from the full molecule, which has a different molecular profile and different pharmacokinetics.
Doesn't exist for the TB-500 fragment. The WADA ban reflects both its performance-enhancing potential and the absence of an established safety record. The cancer-related cell migration concern is biologically grounded: Thymosin Beta-4 is known to be overexpressed in several human cancers, which is why cancer history is an essential screening question.
Biologically credible tissue-repair story grounded in real TB4 science. The key caveat: the TB-500 fragment itself has no human clinical trial data. Cancer history is an essential screening question given TB4's documented overexpression in multiple cancers. If you're a competitive athlete subject to WADA/USADA testing, this is a prohibited substance.